SEMA4C and breast cancer: Furthermore, the increased expression of SEMA4C has also been shown in paclitaxel-resistant BC cell lines compared to their respective parental cell lines, with the resistant phenotype being dependent on SEMA4C expression, thereby suggesting that SEMA4C contributes to resistance to cytotoxics [45].